Last Updated：2025/11/25
Sentence
第I相試験で、乳腺腫瘍を標的とするモノクローナル抗体であるその設計抗体は、乳腺癌細胞に対して選択的な細胞毒性を示した。
Quizzes for review
In the phase I trial the engineered antibody hu-mar-umab demonstrated selective cytotoxicity against mammary carcinoma cells.
See correct answer
In the phase I trial the engineered antibody hu-mar-umab demonstrated selective cytotoxicity against mammary carcinoma cells.
音声機能が動作しない場合はこちらをご確認ください
Related words
English - English
Word Edit Setting
- Users who have edit permission for words - All Users
- Screen new word creation
- Screen word edits
- Screen word deletion
- Screen the creation of new headword that may be duplicates
- Screen changing entry name
- Users authorized to vote on judging - Editor
- Number of votes required for decision - 1
Sentence Edit Setting
- Users who have edit permission for sentences - All Users
- Screen sentence deletion
- Users authorized to vote on judging - Editor
- Number of votes required for decision - 1
Quiz Edit Setting
- Users who have edit permission for quizzes - All Users
- Users authorized to vote on judging - Editor
- Number of votes required for decision - 1
